BSEAGM/EGM26 Oct 2026 · 26 Oct 2026, 07:09 pm
Venmax Drugs and Pharmaceuticals Limited has submitted the Exchange a copy if Scrutinizer report along with voting results of court convened General Meeting held on October 24, 2026.
Venmax Drugs and Pharmaceuticals Ltd · 531015
✦ AI SummaryResults
Venmax Drugs and Pharmaceuticals Ltd has submitted the BSE a copy of the Scrutinizer report along with voting results of the court-convened General Meeting held on October 24, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Venmax Drugs and Pharmaceuticals Ltd - 531015 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report